OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Paediatric Neurology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Analysis of the relation between cerebrospinal fluid antibody titers and clinical characteristics in pediatric patients with anti-N-methyl-D-aspartate receptor encephalitis	81
‘Focal Seizures in Dystonic Cerebral Palsy (DCP): Rare or common or both?	40
Urgent unmet need for pharmaceutical grade vitamin therapy in pyridoxine dependent epilepsies	38
Spinal cord stimulation (SCS) induced favorable neuromodulative outcome in the treatment of chronic neuropathic pain syndrome in children	36
Mental health and behaviour in children with dystonia: Anxiety, challenging behaviour and the relationship to pain and self-esteem	34
Autoimmune encephalitis in Israeli children – A retrospective nationwide study	33
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review	32
A life course perspective on mental disorders and psychopharmacologic drug use among persons living with cerebral palsy	26
Motor imagery ability of children with duchenne muscular dystrophy: Reliability and validity of kinesthetic and Visual Imagery Questionnaire-10, and its association with cognitive status	26
The utility of creatine kinase in status dystonicus and pre-status dystonicus	26
Editorial	25
Associations between muscle morphology and spasticity in children with spastic cerebral palsy	23
CSF IL-6 in pediatric neuroinflammation: Diagnosing disease or driving therapy?	22
Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke	22
Dysmature patterns of newborn EEG recordings: Biological markers of transitory brain dysfunction or brain injury	20
The added value of multimodal neurophysiological tools in the prognostic assessment of perinatal hypoxic-ischemic encephalopathy	20
Comparison of clinical characteristics between cluster and isolated seizures associated with benign convulsions with mild gastroenteritis	20
Quality of life in young adolescents with epilepsy: A case control study	19
Disruptive lesions can cause developmental anomalies in the fetal brain: Mini-review	18
“Fidgety-like movements” in extremely preterm infants - A new entity of spontaneous movements	18
Acute seizures and the risk of post-stroke epilepsy in children with arterial ischemic stroke	17
Clinical presentation, MR imaging and outcome in children with myelin oligodendrocyte glycoprotein antibody-negative acute disseminated encephalomyelitis	16
Unmet health care needs over the first 2 years after pediatric traumatic brain injury	15
Identification of novel pathogenic variants in the GCDH gene and assessment of neurodevelopmental outcomes in 24 children with glutaric aciduria type 1	15
Is late diagnosis of Duchenne muscular dystrophy still a reality?	15

Opioid analgesia and temperature regulation are associated with EEG background activity and MRI outcomes in neonates with mild-to-moderate hypoxic-ischemic encephalopathy undergoing therapeutic hypoth	14
From childhood to adulthood: Long-term assessment of continuous intrathecal baclofen therapy in non-ambulant spastic cerebral palsy	14
Developmental neurobiology of cerebellar and Basal Ganglia connections	14
Safety and recommendations for vaccinations of children with inborn errors of metabolism	14
Outcome measurement instruments in Rett syndrome: A systematic review	13
The development of checklists and reference charts for activities of daily living of normal developing children	13
Migraine and epilepsy: Social cognition skills in pediatric population	13
Genetic causes of infection induced encephalitis	13
Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children	12
The prevalence and clinical relevance of hyperhomocysteinemia suggesting vitamin B12 deficiency in presumed healthy infants	12
Assessing communication, beyond just words	12
Efficacy and tolerability of Melatonin vs Triclofos to achieve sleep for pediatric electroencephalography: A single blinded randomized controlled trial	12
Prevention of infantile spasms in tuberous sclerosis complex	12
Behavioral problems in infants and young children with spinal muscular atrophy and their siblings: A cross-sectional study	12
GLUT1DS focus on dysarthria	12
Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases	11
Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study	11
Dystonia during hand activity in children with spastic unilateral cerebral palsy, an observational study	11
Letter to the Editor in response to Dr. Josef Finsterer et al. “Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants”	11
CSF IL-6 in children with neuroinflammatory conditions	11
Piloting positive psychology resources for caregivers of a child with a genetic developmental and epileptic encephalopathy	11
Gene therapy offers promise, but timing is crucial for SMA treatment	11
Pediatric Neurotuberculosis: A cases series and review of the literature	10
Experience of nusinersen treatment in advanced spinal muscular atrophy type 1: Characteristics of late responders with delayed treatment efficacy	10
Exploring the connections between basal ganglia and cortex revealed by transcranial magnetic stimulation, evoked potential and deep brain stimulation in dystonia	10
Plant-derived cannabinoids for treatment of spasticity in children and adolescents with severe cerebral palsy: Double-blind, placebo-controlled trial	10
CSF-profile and hypocretin levels in children with narcolepsy type 1 and 2	10
Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders	10
Tumefactive demyelinating lesions: navigating the many faces of mimicry	10
Genotype variability in early-onset Hereditary Spastic Paraplegia: a single-center study	10
Cost-effective diagnosis for children with developmental and epileptic encephalopathy phenotype	10
Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes	10
The association of serum vitamin D concentrations in paediatric migraine	10
Sphenoid dysplasia in patients with neurofibromatosis type 1: Clinical features and imaging findings including cerebrospinal fluid alterations	10
Folker Hanefeld, 1937–2022	9
The choroid plexus as a diagnostic tool in Sturge-Weber syndrome	9
Frequency of an intrathecal IgM synthesis and MRZ reaction in children with MS	9
Temporal trends in intraventricular hemorrhage in preterm infants: A Brazilian multicenter cohort	9
Vertigo, pediatric migraine, and best treatment	9
Instrumented classification of patients with early onset ataxia or developmental coordination disorder and healthy control children combining information from three upper limb SARA tests	9
The promise of personalized medicine in pediatric epilepsy – The time has come	9
It's easier to relearn gross motor skills than learn them for the first time after injury: Empirical evidence informing the age at injury debate	9
Editorial Board	9
Health-related quality of life in 153 children with neuromuscular disorders in Latin America: is it age, functional dependence or diagnosis?	9
Prognostic significance of ACTN3 genotype in Duchenne muscular dystrophy: Findings from an Argentine patient cohort	9
Tremor-like subcortical myoclonus in STXBP1 encephalopathy	9
Fat embolism syndrome in Duchenne muscular dystrophy: Report on a novel case and systematic literature review	8
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management	8
Intense work-up is required for pediatric COVID-related acute necrotizing encephalopathy with RANBP2 variants	8
Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution	8

Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational study	8
Limb girdle muscular dystrophies: striving to bridge a diagnostic gap	8
Pathological gait in Rett syndrome: Quantitative evaluation using three-dimensional gait analysis	8
Similar disease progression in nonsense Duchenne muscular dystrophy boys as general natural history: Single Brazilian center 15 years registry view	8
Provoked seizures might lead to a significant diagnosis delay in CLN2	8
Behavioral, neurodevelopmental profile, and epilepsy trajectory in two series of SLC6A1-NDD: A retrospective study with comprehensive assessment, and a participatory database study	8
Genotype – phenotype correlation of Spinal Muscular Atrophy in the era of disease modifying therapies: A tertiary Indian experience	8
Reliability and validity of a newly developed PANDAS/PANS questionnaire	8
ATP1A3-related disorders in the differential diagnosis of acute brainstem and cerebellar dysfunction	8
Autonomic risks in Alternating Hemiplegia of Childhood	7
Is ketogenic diet a ‘precision medicine’? Recent developments and future challenges	7
A practical approach to prenatal diagnosis of malformations of cortical development	7
Are atypical knee jerk responses prognostic for cerebral palsy in high-risk infants and children?	7
Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)	7
Movement disorders, cerebral palsy and vaccination	7
Vaccination and childhood epilepsies	7
Epidemiology of paediatric moderate and severe traumatic brain injury in the Netherlands	7
Deep brain stimulation for phantom limb pain	7
Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec	7
Mid- and long-term (at least 12 months) follow-up of patients with spinal muscular atrophy (SMA) treated with nusinersen, onasemnogene abeparvovec, risdiplam or combination therapies: A systematic rev	7
Ocrelizumab in pediatric patients with MS: Efficacy, tolerability, and safety	7
Neurophysiological recordings improve the accuracy of the evaluation of the outcome in perinatal hypoxic ischemic encephalopathy	7
Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital	6
Dystonia following acquired brain injury (ABI) in childhood – Not as common as we might think?	6
Deepening the understanding of mechanisms of antiepileptic effects of the ketogenic diet in children with AFG2A-related encephalopathy	6
Bradykinesia assessment in children with cerebral palsy and periventricular leukomalacia	6
Long-term monitoring of children with Pseudo Tumor Cerebri Syndrome by transbulbar sonography	6
The use of intrathecal baclofen for management of spasticity in hereditary spastic paraparesis: A case series	6
“Deconstructing” upper limb function in dyskinetic cerebral palsy	6
Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data	6
Neurological and psychiatric phenotype of a multicenter cohort of patients with SETD5-related neurodevelopmental disorder	6
Editorial Board	6
Melatonin usage in children and young adults, a registry-based cohort study	6
Clinical and radiological findings of posterior reversible encephalopathy syndrome in children: About 16 children hospitalized in the pediatric department of a Tunisian tertiary care hospital	6
Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseases	6
Advances in genetics: The start of a new stage for management of focal cortical malformations	6
A novel family illustrating the mild phenotypic spectrum of TUBB2B variants	6
Identification of PMD subgroups using a myelination score for PMD	6
Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome	6
Neurological presentations and cognitive outcome in Sturge-Weber syndrome	6
Reduced elbow muscle strength in children and adolescents with Charcot-Marie-Tooth disease: a case control study	6
Starting a DBS service for children: It’s not the latitude but the attitude - Establishment of the paediatric DBS centre in Northern Finland	6
Room to improve: The diagnostic journey of Spinal Muscular Atrophy	6
Harmful metabolic acidosis in children treated by ketogenic diet during prolonged general anesthesia for epilepsy surgery: A single center experience	6
Neurologic manifestations in children with COVID-19	6
Predicting respiratory failure and outcome in pediatric Guillain-Barré syndrome	6
Phenotypic expansion of EGP5-related Vici syndrome: 15 Dutch patients carrying a founder variant	5
Serum Neurofilament light chain (NfL) levels in children with and without neurologic diseases	5
Reassuring neuropsychological outcome data in myelin oligodendrocyte glycoprotein antibody-associated disease	5
Corrigendum to “Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen”[ Eur. J. Paediatr. Neurol. (2021) 92–10	5
Pediatric vestibular migraine: Diagnosis according to ICHD-3 criteria and the effectiveness of short-term CH prophylaxis	5
Cognitive development after perinatal unilateral infarctions: No evidence for preferential sparing of verbal functions	5
Lesion size and long-term cognitive outcome after pediatric stroke: A comparison between two techniques to assess lesion size	5
Editorial Board	5
Developmental and epileptic encephalopathy 56 due to YWHAG variants: 12 new cases and review of the literature	5
Refining revascularization surgery indications for paediatric moyamoya angiopathy: Age also matters	5
Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature	5
Approach to childhood tremors: Insights from a pediatric neurologist	5
Unravelling key pathways in childhood ataxia to guide diagnosis and treatment	5
Efficacy and safety of Nusinersen among children with spinal muscular atrophy from North India: A prospective cohort study (NICE-SMA study)	5